Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7385052 | 0.98 | AGXT (0.46) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 | |
| SCHEMBL15961256 | 0.98 | TSHR (0.46) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 | |
| Ethylene Glycol SCHEMBL28921702 | 0.94 | TSHR (0.43) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 | |
| SCHEMBL29035063 | 0.92 | TSHR (0.41) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 | |
| Butane SCHEMBL1238313 | 0.92 | ALDH1A1 (0.46) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 | |
| SCHEMBL20589969 | 0.90 | ALDH1A1 (0.44) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 | |
| Aniline SCHEMBL29187471 | 0.89 | MAOB (0.50) | TSHRALDH1A1L3MBTL1IDO1AGXT | |
| Aniline SCHEMBL29187472 | 0.89 | MAOB (0.50) | TSHRALDH1A1L3MBTL1IDO1AGXT | |
| SCHEMBL29255545 | 0.87 | PTGS1 (0.59) | SLC6A2SLC6A3L3MBTL1LMNACYP1A2 | |
| Di(Hydroxyethyl)Ether SCHEMBL28629273 | 0.87 | TSHR (0.42) | TSHRALDH1A1SLC6A2SLC6A3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105686-A1 | A PROCESS FOR THE SYNTHESIS OF STILBENE AND INTERMEDIATES THEREOF | FERTIS INDIA PVT LTD (IN) | 2024-05-23 | — | — | WO | claimed |
| EP-3107647-B1 | PROCESS FOR FORMING DUST-FREE ADDITIVE GRANULES | SI GROUP SWITZERLAND CHAA GMBH (CH) | 2020-12-23 | — | — | EP | claimed |
| US-20180052952-A9 | METHODS AND APPARATUS FOR DOUBLE-INTEGRATION ORTHOGONAL SPACE TEMPERING | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2018-02-22 | — | — | US | claimed |
| US-20170014790-A1 | Process | ADDIVANT SWITZERLAND GMBH (CH) | 2017-01-19 | — | — | US | claimed |
| EP-3107647-A2 | PROCESS FOR FORMING DUST-FREE ADDITIVE GRANULES | Addivant Switzerland GmbH (CH) | 2016-12-28 | — | — | EP | claimed |
| CN-103172512-B | A group of compounds with similar cajanin structure, preparation method and application | 中国医学科学院医药生物技术研究所 | 2016-08-03 | — | — | CN | claimed |
| US-9310544-B2 | Polarizer and display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-12 | — | — | US | claimed |
| US-20150226893-A1 | POLARIZER, DISPLAY DEVICE INCLUDING THE SAME AND METHOD OF MANUFACTURING THE POLARIZER | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-08-13 | — | — | US | claimed |
| US-20140371232-A1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2014-12-18 | — | — | US | claimed |
| EP-2796442-A1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) | 2014-10-29 | — | — | EP | claimed |
| EP-0206000-A1 | (2,3)-Alpha-methylenepenam-3-carboxylic acids and derivatives thereof | F. HOFFMANN-LA ROCHE AG (CH) | 1986-12-30 | — | — | EP | claimed |
| EP-0187355-A1 | Process for preparing beta-lactam antibiotics | E.R. Squibb & Sons, Inc. (US) | 1986-07-16 | — | — | EP | claimed |
| US-4533660-A | Antibacterial O-sulfated β-lactam hydroxamic acids | E. R. SQUIBB & SONS, INC. (US) | 1985-08-06 | — | — | US | claimed |
| EP-0051381-B1 | O-SULFATED BETA-LACTAM HYDROXAMIC ACIDS | E.R. Squibb & Sons, Inc. (US) | 1985-01-30 | — | — | EP | claimed |
| EP-0032586-B1 | DURABLE POLYESTER MOLDING COMPOSITION | GAF CORPORATION (US) | 1984-01-11 | — | — | EP | claimed |
| EP-0051381-A1 | O-sulfated beta-lactam hydroxamic acids | E.R. Squibb & Sons, Inc. (US) | 1982-05-12 | — | — | EP | claimed |
| EP-0048953-A2 | Beta-lactam antibiotics | E.R. Squibb & Sons, Inc. (US) | 1982-04-07 | — | — | EP | claimed |
| EP-0032586-A2 | Durable polyester molding composition | GAF CORPORATION (US) | 1981-07-29 | — | — | EP | claimed |
| US-4277391-A | CONTAINING THREE DIFFERENT TYPES OF ANTIOXIDANTS | GAF CORPORATION (US) | 1981-07-07 | — | — | US | claimed |
| US-4250320-A | Process for producing substituted benzoxaphospholes | MONSANTO COMPANY (US) | 1981-02-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371232-A1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | ACHE, GAP43, LNPK | TSHR 4767/4885ALDH1A1 2762/4885SLC6A2 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.